Where Will Cisco Systems Stock Be in 10 Years?
Cisco Systems, Inc. (NASDAQ:CSCO) has enjoyed its position as a…
Buy
62
ENFN Quote, Financials, Valuation and Earnings
Last price:
$10.30
Seasonality move
:
-11.71%
Day range:
$10.05 - $10.39
52-week range:
$7.52 - $11.38
Dividend yield:
0%
P/E ratio:
254.00x
P/S ratio:
6.18x
P/B ratio:
13.71x
Volume:
385.1K
Avg. volume:
461.8K
1-year change:
10.8%
Market cap:
$958.8M
Revenue:
$174.5M
EPS (TTM):
$0.04
Earnings Data
Next earnings date for ENFN
Mar 12
2025
Most recent earnings per share
$0.02
Missed by $0.04
(Nov 4/2024)
Consensus Estimate
$0.06
(Nov 4/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ENFN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | $56.4M | -- | -- | $0.06 | -- |
| 03/12/2025 | Q4 | $54.7M | -- | -- | $0.06 | -- |
| 11/04/2024 | Q3 | $52.2M | $51.2M | $0.02 | $0.06 | -$0.04 |
| 08/06/2024 | Q2 | $50M | $49.5M | $0.02 | $0.06 | -$0.04 |
| 05/09/2024 | Q1 | $47.6M | $48.1M | -$0.01 | $0.04 | -$0.05 |
| 03/12/2024 | Q4 | $45.1M | $46.5M | $0.01 | $0.05 | -$0.04 |
| 11/07/2023 | Q3 | -- | -- | $0.02 | $0.05 | -$0.03 |
| 08/08/2023 | Q2 | -- | -- | $0.01 | $0.04 | -$0.03 |
| 05/09/2023 | Q1 | -- | -- | $0.04 | $0.03 | $0.01 |
| 03/07/2023 | Q4 | -- | -- | $0.01 | $0.03 | -$0.02 |
| 11/10/2022 | Q3 | -- | -- | $0.02 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.03 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.10 | -- | -- |
| 03/24/2022 | Q4 | -- | -- | -$2.26 | -- | -- |
| 12/02/2021 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $0.07 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.19 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $0.09 | -- | -- |
Enfusion Earnings Questions
-
How Much did Enfusion Generate in Revenue Last Quarter?
Enfusion reported $51.2M worth of top line sales in its most recent quarter.
-
Did Enfusion Beat Earnings Last Quarter?
Enfusion announced earnings per share of $0.02 which represents a miss of analyst forecast a $0.06 per share.
-
Is Enfusion Profitable?
Enfusion reported $34.8M that represents $0.27 per share over the last quarter.
-
What is the Analyst Consensus for Enfusion EPS Next Year?
Enfusion's earnings are forecast to grow from $0.07 per share to $0.21 per share next year representing an increase of 202.96%.
-
When is Enfusion's Earnings Date?
Enfusion's next earnings date is March 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Disney vs Estée Lauder Stock, Which Is Best?
Inflation has eaten away at a lot of the money…
Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is down 0.23% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 4.97% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 8.78% over the past day.
